FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure
Stefan D. Anker, MD, PhD
Mahir Karakas, MD, PhD, MBA
Impact of Barostim on Heart Failure Hospitalization
Jacob Abraham, MD
Optimizing AAV Outcomes: Maintenance Therapies
Bernhard Hellmich, MD
Silke R. Brix, MD, MRCP, SCPR
Tailoring Treatment for Optimal Outcomes in Patients With AAV
Andreas Kronbichler, MD
Implementing the SOC Induction Therapies in AAV
Managing Patients With AAV in the Rheumatology Clinic
Don't Miss It! Rapid & Accurate AAV Diagnosis
Elevating Care for Patients With Severe Renal Disease in AAV
Pearls of Wisdom: Optimizing Hyperkalemia Management in Patients with CKD
Matthew R. Weir, MD
Nihar Desai, MD
Ellie Kelepouris, MD, FACP, FAHA
Beyond the Broadcast: Expert Insights on SGLT2 Inhibitors in Cardiometabolic Care
Melissa Magwire, RN, MSN, CDE
Matthew Bullington, PharmD
Dawn M. Denicola, FNP-C
Keith Miller, MD
Breaking the Cycle: Addressing Hyperkalemia in CKD and Heart Failure to Optimize RAASi Therapy
Mikhail Kosiborod, MD
Stephen J. Greene, MD, FACC, FHFSA
Refining Strategies for Enhancing Cardiorenal Outcomes With SGLT2 Inhibitors: Optimizing the Cardiometabolic Care Model
Pulmonary Hypertension: Diagnosis, Management, and Updates – Chairperson’s Perspective
Vallerie V. McLaughlin, MD
Cardiorenal Collaboration: Escape the Treatment Trap
The Shifting ATTR-CM Landscape: Early Diagnosis, Emerging Therapies & Personalized Care
Pablo Garcia-Pavia, MD, PhD
Francesco Cappelli, MD
Cardiorenal Collaboration: Optimizing Multidisciplinary Care in the CvRM Patient
Raymond Townsend, MD
Michael Weber, MD